AI Science Tracker
EN

Analytical Validation of Multimodal AI Test Predicting Breast Cancer Recurrence Risk (Ataraxis Breast RISK).

Affiliation not stated in the reviewed material · 29 Mar 2026 · medicine

Discovery

Analytical Validation of Multimodal AI Test Predicting Breast Cancer Recurrence Risk (Ataraxis Breast RISK).

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: A locked H&E-image and clinical-data AI test passed prespecified repeatability and reproducibility checks in 160 breast-cancer cases, including 94.7% agreement across two laboratories/scanners. This is analytical readiness evidence, not independent clinical utility evidence.

Technology: Kestrel vision-transformer patch embeddings are attention-aggregated, combined with clinical variables, and scored by an ensemble of Cox neural networks with calibration.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Kestrel vision-transformer patch embeddings are attention-aggregated, combined with clinical variables, and scored by an ensemble of Cox neural networks with calibration.
Limitation / still unknown
Prespecified analytical acceptance criteria were assessed using repeat runs, two operators, two labs/scanners, controls, perturbed covariates and a clinical-validation bridge; cohort was retrospective and largely ER-positive/HER2-negative, limiting generalization.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13073172/ · https://europepmc.org/article/MED/41975736

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.